Silicon Republic December 6, 2024
Ciarán Mather

The funds will be used to drive the development of its innovative product, which aims to increase the safety of C-section surgery.

Maternal health start-up Nua Surgical announced today (6 December) that it has secured €6.5m in Series A funding to develop and commercialise its SteriCision C-section retractor.

The Galway-based business’ device gives obstetricians hands-free, unobstructed access to the uterus during C-section surgery, which, the company said, reduces the risk of wound trauma and facilitates safer procedures.

Using the funds, the medtech company will drive the manufacturing, testing, regulatory clearance and early commercialisation of its product. This involves expanding the team, establishing manufacturing in Ireland and meeting the regulatory requirements necessary to gain FDA clearance.

According to Nua Surgical, the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Medical Devices, Trends
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry
Cala Health Snags $50M for At-Home Tremor Relief Therapy

Share This Article